Startups, equipment vendors, and service providers warily gear up for fixed-mobile convergence. Ommm.
|
Sanofi-Aventis’ $3.5-billion blood-thinning drug is no better than aspirin.
|
Next generation of base stations and wireless technology highlight company’s latest mobile push.
|
Dutch publisher VNU will pay $7 billion for drug market research company IMS Health.
|
Jeffrey Jaffe explains how nanotechnology will help turn Lucent’s futuristic telecom dreams into reality.
|
Maybe he never knew when to walk away, or when to run, but entrepreneur Jawad Ayaz’ riskier bets are starting to look smart.
|